Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
- 28 December 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Purinergic Signalling
- Vol. 9 (2), 145-165
- https://doi.org/10.1007/s11302-012-9349-9
Abstract
Cancer is a chronic disease and its pathogenesis is well correlated with infection and inflammation. Adenosine is a purine nucleoside, which is produced under metabolic stress like hypoxic conditions. Acute or chronic inflammatory conditions lead to the release of precursor adenine nucleotides (adenosine triphosphate (ATP), adenosien diphosphate (ADP) and adenosine monophosphate (AMP)) from cells, which are extracellularly catabolized into adenosine by extracellular ectonucleotidases, i.e., CD39 or nucleoside triphosphate dephosphorylase (NTPD) and CD73 or 5′-ectonucleotidase. It is now well-known that adenosine is secreted by cancer as well as immune cells during tumor pathogenesis under metabolic stress or hypoxia. Once adenosine is released into the extracellular environment, it exerts various immunomodulatory effects via adenosine receptors (A1, A2A, A2B, and A3) expressed on various immune cells (i.e., macrophages, myeloid-derived suppressor cells (MDSCs), natural killer (NK) cells, dendritic cells (DCs), T cells, regulatory T cell (Tregs), etc.), which play very important roles in the pathogenesis of cancer. This review is intended to summarize the role of inflammation and adenosine in the immunopathogenesis of tumor along with regulation of tumor-specific immune response and its modulation as an adjunct approach to tumor immunotherapy.Keywords
This publication has 163 references indexed in Scilit:
- The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsSeminars in Immunopathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- FcRγ Activation Regulates Inflammation-Associated Squamous CarcinogenesisCancer Cell, 2010
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsCancer Immunology, Immunotherapy, 2008
- The macrophage: Past, present and futureEuropean Journal of Immunology, 2007
- From ‘Hellstrom Paradox–to anti-adenosinergic cancer immunotherapyPurinergic Signalling, 2007
- Adenosine and lymphocyte regulationPurinergic Signalling, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006